At its debut trading on Thursday, June 17 Verve Therapeutics, Inc. (VERV) showed a 68% increase and by the end of the day closed at $31.92. Shortly before the company had placed its shares in an IPO at a price of $19 per share.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей